News | Radiation Dose Management | February 28, 2017

ACR Updates Guidelines for NEMA XR-29 CT Dose Standard

Document states Medic Vision’s SafeCT-29 is the only FDA- and CMS-approved third-party vendor XR-29 upgrade product

ACR, guideline update, NEMA XR-29 Smart Dose Standard, Medic Vision, SafeCT-29

February 28, 2017 — The American College of Radiology (ACR) published updated guidelines regarding the NEMA XR-29 (MITA Smart Dose) Standard, finally setting a clear and specific set of guidelines for an acceptable Certificate of NEMA XR-29 Compliance. The publication specifically declares, "certificates of NEMA XR-29 Compliance from third-party vendors are acceptable if: (1) The third-party vendor has obtained the required FDA [U.S. Food and Drug Administration] 510(K) pre-market clearance for their upgrade product; and (2) The third-party vendor upgrade product has been approved by CMS [Centers for Medicare and Medicaid Services]."

Furthermore, the document states, "Currently, the only FDA- and CMS-approved third-party vendor NEMA XR-29 upgrade product is the Medic Vision SafeCT-29."

The SafeCT-29 system is an add-on system that helps achieve compliance with the XR-29 Standard for computed tomography (CT) and positron emission tomography (PET)/CT systems equipped with automatic exposure control (AEC) and Reference protocols. SafeCT-29 provides the XR-29 Dose Check and RDSR functions. It is the first and only FDA 510k-cleared third-party solution on the market, according to Medic vision.

The timing of this guideline announcement is critical, according to Medic Vision, as CMS penalties for non-compliance triple this year. Health institutes that did not receive OEM support for XR-29 compliance and did not purchase SafeCT-29 as a third-party FDA-cleared solution for CT and PET/CT scanners, may now have to start over and potentially be subject to the 15 percent CMS penalty, which went into effect on Jan. 1, 2017.

For more information: www.medicvision.com


Additional Content

News | Computed Tomography (CT)

Nov. 7, 2026 — Cleerly presented primary results from PARAMOUNT, the first randomized trial of AI-QCT-guided care ...

Home November 09, 2026
Home
News | Computed Tomography (CT)

Oct. 26, 2026 — Coreline Soft has received U.S. Food and Drug Administration (FDA) 510(k) clearance for AVIEW Aorta ...

Home October 26, 2026
Home
News | Computed Tomography (CT)

Aug. 31, 2026 — Caristo Diagnostics has announced new independent University of Oxford-led research showing that Caristo ...

Home September 04, 2026
Home
News | Computed Tomography (CT)

July 23, 2026 — HOPPR has introduced HOPPR EF Chest CT Narrative Model, a foundation model that processes 3D chest CT ...

Home July 23, 2026
Home
Feature | Computed Tomography (CT) | Kyle Hardner

A physical exam and echocardiogram have been the traditional tools for diagnosing aortic stenosis. Yet many patients ...

Home June 17, 2026
Home
Subscribe Now